MTAP and central nervous system cancer: Also based on the glioma subtype analysis, they have shown that all the subtypes showed more than 50% MTAP gene expression loss except for the G-CIMP (Glioma-CpG Island Methylator Phenotype) subtype, and the classical subtype showed the highest frequency of loss of MTAP gene expression.